Hongshi Capital
Overview
Hongshi Capital is a venture capital and private equity firm based in Hangzhou, China, that invests in healthcare, consumer, and technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SYNUS Tech | Dec 2025 | Series A Extension | Co-investor |
| Hunan New Frontier Technology Group Co., Ltd. | Aug 2023 | Series A | Co-investor |
| JHM Biopharmaceutical (Hangzhou) Co., Ltd. | Oct 2022 | Series A | Co-investor |
| Changsha Chixin Semiconductor Technology Co., Ltd. | Aug 2022 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hongshi Capital based?
Hongshi Capital is headquartered in Hangzhou, China.
When was Hongshi Capital founded?
Hongshi Capital was founded in 2015.
How many portfolio companies does Hongshi Capital have?
Hongshi Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Hongshi Capital's portfolio?
Recent investments visible on Caplight include SYNUS Tech, Hunan New Frontier Technology Group Co., Ltd., JHM Biopharmaceutical (Hangzhou) Co., Ltd., Changsha Chixin Semiconductor Technology Co., Ltd..
What was Hongshi Capital's most recent investment?
Hongshi Capital's most recent investment on Caplight was in SYNUS Tech in 2025.
What sectors does Hongshi Capital focus on?
Hongshi Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Telecommunications & Networking, Energy & Sustainability, Mobility, Transportation & Logistics.
What company stages does Hongshi Capital focus on?
Hongshi Capital typically invests at the Early stage.